月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
篇名
Reduction of plasma adiponectin and elevation of plasma retinol-binding protein 4 in patients with primary gouty arthritis
作者 Qibin YangYong-Long HeYufeng QingDan JiangMin LiWen-Guang XieJing-Guo Zhou
英文摘要
Objective: This study aims to investigate the relationship between plasma levels of adipocytokines [adiponectin and retinol-binding protein 4 (RPB4)] and uric acid in patients with primary gouty arthritis (GA).
Methods: 88 primary GA patients and 80 healthy controls (HCs) were enrolled. Clinical data were collected, fasting blood samples were obtained for biochemical examinations such as plasma adiponectin and RBP4 levels, and urine samples were taken for measurement of RBP4 concentrations.
Results: In comparison with HCs, the levels of plasma adiponectin (6.52 ± 6.31 vs 8.46 ± 6.17 μg/ml, P=0.046) were significantly lower, but plasma RBP4 (189.34 ± 126.76 vs 44.17 ± 14.57 ng/ml, P<0.001) and urinary RBP4 (2.44 ± 1.50 vs 0.38 ± 0.16 ng/ml, P<0.001) were markedly higher in GA patients. In GA patients with renal calculus, urinary RBP4 concentrations were even higher compared to those without renal calculus (2.76 ± 1.10 vs 1.30 ± 0.54 ng/ml, P<0.001). In GA patients, uric acid levels were negatively correlated with plasma adiponectin levels (r=-0.36, P<0.001), but positively correlated with plasma RBP4 (r=0.33, P<0.001).
Conclusion: Adiponectin and RBP4 might be involved in the regulation of plasma uric acid and lipid metabolism in GA patients, thus contributing to the pathogenesis of gouty inflammation.
起訖頁 50-55
關鍵詞 AdiponectinRetinol-binding protein 4Uric acidGouty arthritis
刊名 Gout and Hyperuricemia
出版單位 Gout and Hyperuricemia
期數 201506 (2:2期)
DOI 10.3966/GH1506020202  複製DOI  DOI申請
QRCode
 



讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄